Drug Profile
G28-5 sFv-PE40
Alternative Names: G28-5s Fv-PE40Latest Information Update: 18 Jan 2008
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Drug conjugates; Immunotoxins
- Mechanism of Action CD40 antigen inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 18 Jan 2008 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 28 May 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 05 Oct 1998 Profile reviewed but no significant changes made